Food and Drug Administration Commissioner Stephen Hahn announces at a White House press conference that convalescent plasma has received emergency use authorization as a coronavirus treatment.
The language of the press conference is less about the emergency use authorization and more promoting convalescent plasma as a new discovery, made possible only by Donald Trump.
The conference is also based on lies.
The most obvious lie called out by critics is that COVID-19 patients treated with convalescent plasma showed a “35% improvement in survival” compared to other patients. That number is impossible. A 35% reduction in mortality suggests that 35 people out of 100 who get the virus will be saved because of the treatment. Currently, only 1 out of 100 people infected die.
If 1,000 people get the virus, only 10 people will die, so convalescent plasma would potentially save three or four people.
Hahn admits the next day that he over exaggerated the effectiveness of plasma transfusion as a COVID-19 treatment.
The announcement comes just one day after Donald Trump publicly attacked the FDA, accusing Hahn of trying to delay COVID-19 treatments until after the election.
Statements from the FDA about the treatment raised suspicion immediately.
On Friday, August 28th, Hahn announces that he is firing FDA spokesperson Emily Miller (as long as the White House signs off on it). Health officials tell Politico that she is the worst person for the job and can’t even pronounce “convalescent plasma.” That last part’s funny because Donald Trump can’t, either.
Photo: Public Domain